Róbert Sike

470 total citations · 1 hit paper
9 papers, 376 citations indexed

About

Róbert Sike is a scholar working on Genetics, Genetics and Hematology. According to data from OpenAlex, Róbert Sike has authored 9 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Genetics and 4 papers in Hematology. Recurrent topics in Róbert Sike's work include Chronic Lymphocytic Leukemia Research (7 papers), Inflammatory Bowel Disease (7 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Róbert Sike is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Inflammatory Bowel Disease (7 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Róbert Sike collaborates with scholars based in Hungary, Poland and Russia. Róbert Sike's co-authors include Séverine Vermeire, Robert Petryka, Stefan Schreiber, Xavier Roblin, Adrian Goldiș, Maria Kłopocka, Tanja Kuehbacher, Pille Harrison, Chantal Tasset and Annegret Van der Aa and has published in prestigious journals such as The Lancet, Gastroenterology and Journal of Crohn s and Colitis.

In The Last Decade

Róbert Sike

9 papers receiving 370 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

2016 344 citations Séverine Vermeire, Stefan Schreiber et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Róbert Sike Hungary	5	258	152	109	92	91	9	376
Alexandre Aubourg France	7	166 0.6×	125 0.8×	119 1.1×	41 0.4×	47 0.5×	13	299
Willem-Jan Wollants Belgium	6	287 1.1×	167 1.1×	144 1.3×	25 0.3×	22 0.2×	9	404
Martina Goetsch United States	7	218 0.8×	125 0.8×	61 0.6×	27 0.3×	15 0.2×	40	296
Nathalie Clerget–Chossat France	5	99 0.4×	45 0.3×	259 2.4×	75 0.8×	14 0.2×	5	358
A. Parikh United States	6	217 0.8×	180 1.2×	120 1.1×	60 0.7×	9 0.1×	14	335
Jacek Romatowski Poland	7	95 0.4×	57 0.4×	47 0.4×	39 0.4×	19 0.2×	16	201
Ignatius Chua United Kingdom	8	87 0.3×	55 0.4×	202 1.9×	60 0.7×	13 0.1×	13	288
Floris C. Loeff Netherlands	9	40 0.2×	30 0.2×	125 1.1×	37 0.4×	64 0.7×	23	331
Shunichiro Takezaki Japan	8	63 0.2×	157 1.0×	183 1.7×	21 0.2×	77 0.8×	30	316
Marcoli Cyrille United States	8	127 0.5×	60 0.4×	106 1.0×	20 0.2×	10 0.1×	14	277

Countries citing papers authored by Róbert Sike

Since Specialization

Citations

This map shows the geographic impact of Róbert Sike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róbert Sike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róbert Sike more than expected).

Fields of papers citing papers by Róbert Sike

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Róbert Sike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róbert Sike. The network helps show where Róbert Sike may publish in the future.

Co-authorship network of co-authors of Róbert Sike

This figure shows the co-authorship network connecting the top 25 collaborators of Róbert Sike. A scholar is included among the top collaborators of Róbert Sike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Róbert Sike. Róbert Sike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

D’Haens, Geert, Stefan Schreiber, Tanja Kuehbacher, et al.. (2017). DOP075 Efficacy of filgotinib, a selective JAK1 inhibitor, is independent of prior anti-TNF exposure: subgroup analysis of the phase 2 FITZROY study in moderate-to-severe Crohn's disease. Journal of Crohn s and Colitis. 11(suppl_1). S70–S71. 1 indexed citations

2.

Vermeire, Séverine, Stefanie Schreiber, Tanja Kuehbacher, et al.. (2017). OP023 Maintenance of clinical effect in patients with moderate-to-severe Crohn's disease treated with filgotinib, a selective JAK1 inhibitor: exploratory 20-week data analysis of the phase 2 FITZROY study. Journal of Crohn s and Colitis. 11(suppl_1). S13–S14. 4 indexed citations

3.

D’Haens, Geert, Stefan Schreiber, Robert Petryka, et al.. (2017). Efficacy of Filgotinib, a Selective jak1 Inhibitor, is Independent of Prior Anti-TNF Exposure: Subgroup Analysis of the Phase 2 Fitzroy Study in Moderate-To-Severe Crohn’s Disease. Gastroenterology. 152(5). S597–S597. 1 indexed citations

4.

Vermeire, Séverine, Stefan Schreiber, Robert Petryka, et al.. (2017). Maintenance of Clinical Effect in Patients with Moderate-to-Severe Crohn’s Disease Treated with Filgotinib, a Selective jak1 Inhibitor: Exploratory 20-Week Data Analysis of the Phase 2 Fitzroy Study. Gastroenterology. 152(5). S601–S601. 1 indexed citations

5.

Vermeire, Séverine, Stefan Schreiber, Robert Petryka, et al.. (2016). Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. The Lancet. 389(10066). 266–275. 344 indexed citations breakdown →

6.

Vermeire, Séverine, Stefan Schreiber, Tanja Kuehbacher, et al.. (2016). Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn's disease: interim analysis from the Phase 2 FITZROY study. 5 indexed citations

7.

Vermeire, Séverine, Stefan Schreiber, Robert Petryka, et al.. (2016). 812c Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor, Induces Clinical Remission in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 2 FITZROY Study Interim Analysis. Gastroenterology. 150(4). S1267–S1267. 9 indexed citations

8.

Demeter, Pál, et al.. (2003). [Comparison of the effectiveness and tolerability of the saccharosum-sennosid-B solution and sodium-picosulfate in preparation for colonoscopy. Prospective, multicenter, randomized study].. PubMed. 144(32). 1587–90. 2 indexed citations

9.

Kozak, Robert, et al.. (1999). [Helicobacter pylori infection in diabetic patients].. PubMed. 140(18). 993–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact